These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 24708836)

  • 1. Combined effect of hyperfiltration and renin angiotensin system activation on development of chronic kidney disease in diabetic db/db mice.
    Hartono SP; Knudsen BE; Lerman LO; Textor SC; Grande JP
    BMC Nephrol; 2014 Apr; 15():58. PubMed ID: 24708836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
    Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
    Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of renal atrophy in murine 2 kidney 1 clip hypertension is strain independent.
    Kashyap S; Boyilla R; Zaia PJ; Ghossan R; Nath KA; Textor SC; Lerman LO; Grande JP
    Res Vet Sci; 2016 Aug; 107():171-177. PubMed ID: 27473991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal hemodynamics and renin-angiotensin system activity in humans with multifocal renal artery fibromuscular dysplasia.
    van Twist DJ; Houben AJ; de Haan MW; de Leeuw PW; Kroon AA
    J Hypertens; 2016 Jun; 34(6):1160-9. PubMed ID: 27032075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
    Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new low-nephron CKD model with hypertension, progressive decline of renal function, and enhanced inflammation in C57BL/6 mice.
    Wei J; Zhang J; Wang L; Cha BJ; Jiang S; Liu R
    Am J Physiol Renal Physiol; 2018 May; 314(5):F1008-F1019. PubMed ID: 29412703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renin-angiotensin system blockade alone or combined with ET
    Sedláková L; Čertíková Chábová V; Doleželová Š; Škaroupková P; Kopkan L; Husková Z; Červenková L; Kikerlová S; Vaněčková I; Sadowski J; Kompanowska-Jezierska E; Kujal P; Kramer HJ; Červenka L
    Clin Exp Hypertens; 2017; 39(2):183-195. PubMed ID: 28287881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronotherapy with a Renin-angiotensin System Inhibitor Ameliorates Renal Damage by Suppressing Intrarenal Renin-angiotensin System Activation.
    Aoki T; Ohashi N; Isobe S; Ishigaki S; Matsuyama T; Sato T; Fujikura T; Kato A; Miyajima H; Yasuda H
    Intern Med; 2020; 59(18):2237-2244. PubMed ID: 32938851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential renal effects of candesartan at high and ultra-high doses in diabetic mice-potential role of the ACE2/AT2R/Mas axis.
    Callera GE; Antunes TT; Correa JW; Moorman D; Gutsol A; He Y; Cat AN; Briones AM; Montezano AC; Burns KD; Touyz RM
    Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27612496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of blood pressure and the renin-angiotensin system in development of diabetic nephropathy (DN) in eNOS-/- db/db mice.
    Zhang MZ; Wang S; Yang S; Yang H; Fan X; Takahashi T; Harris RC
    Am J Physiol Renal Physiol; 2012 Feb; 302(4):F433-8. PubMed ID: 22114203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension and renal injury in experimental polycystic kidney disease.
    Kennefick TM; Al-Nimri MA; Oyama TT; Thompson MM; Kelly FJ; Chapman JG; Anderson S
    Kidney Int; 1999 Dec; 56(6):2181-90. PubMed ID: 10594794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Klotho protein supplementation reduces blood pressure and renal hypertrophy in db/db mice, a model of type 2 diabetes.
    Takenaka T; Kobori H; Miyazaki T; Suzuki H; Nishiyama A; Ishii N; Yamashita M; Hayashi M
    Acta Physiol (Oxf); 2019 Feb; 225(2):e13190. PubMed ID: 30251773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II type 1 receptor-associated protein deletion combined with angiotensin II stimulation accelerates the development of diabetic kidney disease in mice on a C57BL/6 strain.
    Taguchi S; Azushima K; Yamaji T; Suzuki T; Abe E; Tanaka S; Hirota K; Tsukamoto S; Morita R; Kobayashi R; Kinguchi S; Yamashita A; Wakui H; Tamura K
    Hypertens Res; 2024 Jan; 47(1):55-66. PubMed ID: 37957242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor glycemic control and decreased renal function are associated with increased intrarenal RAS activity in Type 2 diabetes mellitus.
    Nakatani S; Ishimura E; Naganuma T; Nakatani A; Ichii M; Fukumoto S; Mori K; Emoto M; Nakatani T; Inaba M
    Diabetes Res Clin Pract; 2014 Jul; 105(1):40-6. PubMed ID: 24846444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice.
    Lo CS; Liu F; Shi Y; Maachi H; Chenier I; Godin N; Filep JG; Ingelfinger JR; Zhang SL; Chan JS
    Am J Physiol Renal Physiol; 2012 Apr; 302(7):F840-52. PubMed ID: 22205225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Klotho Ameliorates Kidney Injury and Fibrosis and Normalizes Blood Pressure by Targeting the Renin-Angiotensin System.
    Zhou L; Mo H; Miao J; Zhou D; Tan RJ; Hou FF; Liu Y
    Am J Pathol; 2015 Dec; 185(12):3211-23. PubMed ID: 26475416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Inhibition of Soluble Epoxide Hydrolase and Renin-Angiotensin System Exhibits Superior Renoprotection to Renin-Angiotensin System Blockade in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats with Established Chronic Kidney Disease.
    Čertíková Chábová V; Kujal P; Škaroupková P; Varňourková Z; Vacková Š; Husková Z; Kikerlová S; Sadowski J; Kompanowska-Jezierska E; Baranowska I; Hwang SH; Hammock BD; Imig JD; Tesař V; Červenka L
    Kidney Blood Press Res; 2018; 43(2):329-349. PubMed ID: 29529602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renovascular hypertension: Effects of mesenchymal stem cells in the contralateral hypertensive kidney in rats.
    Oliveira-Sales EB; Varela VA; Maquigussa E; Borges FT; Shimoura CG; Gomes G; Campos RR; Boim MA
    Clin Exp Hypertens; 2016; 38(7):586-593. PubMed ID: 27649588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model.
    Leelahavanichkul A; Yan Q; Hu X; Eisner C; Huang Y; Chen R; Mizel D; Zhou H; Wright EC; Kopp JB; Schnermann J; Yuen PS; Star RA
    Kidney Int; 2010 Dec; 78(11):1136-53. PubMed ID: 20736988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Effects of Direct Renin Inhibitor and Angiotensin Receptor Blocker on Albuminuria in Hypertensive Patients with Type 2 Diabetes. A Randomized Controlled Trial.
    Uzu T; Araki SI; Kashiwagi A; Haneda M; Koya D; Yokoyama H; Kida Y; Ikebuchi M; Nakamura T; Nishimura M; Takahara N; Obata T; Omichi N; Sakamoto K; Shingu R; Taki H; Nagai Y; Tokuda H; Kitada M; Misawa M; Nishiyama A; Kobori H; Maegawa H;
    PLoS One; 2016; 11(12):e0164936. PubMed ID: 28033332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.